nafithromycin: Clinical Trials

6 trials of nafithromycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 21Completed 1

Follow nafithromycin: new trials by email Literature Review of nafithromycin trials Research Report on nafithromycin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin
Nafithromycin, Placebo - Healthy
Phase 1CompletedWockhardt102019-06-182019-10-02
Phase II Study of Oral Nafithromycin in CABP
Nafithromycin 800 mg 3 days, Nafithromycin 800 mg 5 days, Moxifloxacin 400 mg - Community-Acquired Bacterial Pneumonia (CABP)
Phase 2CompletedWockhardt2312016-11-182019-12-20
A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects
Nafithromycin, Placebo - Healthy Volunteers
Phase 1CompletedWockhardt602016-04-252018-08-01
Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
WCK 4873 - Healthy
Phase 1CompletedWockhardt362015-04-012015-08-03
Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult Volunteers
WCK 4873, Placebo Oral Tablet - Healthy
Phase 1CompletedWockhardt302013-08-202019-06-11
The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers
WCK 4873, Placebo Oral Tablet - Healthy
Phase 1CompletedWockhardt672013-03-142019-04-25

Sponsors

Wockhardt (6)

Countries

United States (4)

Top investigators

Ashima Bhatia, MD PDCR (1)  ·  Carlos Sanabria, MD (1)

Results publications

PMID 28696231